BAKER & HOSTETLER LLP for C.R. BARD INC.
What was lobbied
2 issue areas, each in the filer's own words, with who lobbied on it and where.
Taxation/Internal Revenue Code TAX
H.R. 1865, the Further Consolidated Appropriations Act, 2020, specifically Section 501, repeal of the medical device excise tax. S. 692, the Protect Medical Innovation Act. H.R. 2207, the Protect Medical Innovation Act.
| Lobbyist | Covered position, as disclosed |
|---|---|
| ADAM HIGGINS | — |
| CHRIS JONES | — |
| TYLER THOMPSON | — |
Health Issues HCR
Regulatory and reimbursement policy issues related to federal healthcare programs, including Medicare and Medicaid. H.R. 2113, the Prescription Drug Sunshine, Transparency, Accountability and Reporting Act, including medical device product samples reporting. H.R. 2296, the FAIR Drug Pricing Act, including medical device product samples reporting.
| Lobbyist | Covered position, as disclosed |
|---|---|
| ADAM HIGGINS | — |
| CHRIS JONES | — |
| TYLER THOMPSON | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.